CSIMarket


Alexion Pharmaceuticals Inc   (ALXN)
Other Ticker:  
 


 

Alexion Pharmaceuticals Inc

ALXN's Financial Statements and Analysis



Alexion Pharmaceuticals Inc reported II. Quarter net loss per share of $-4.84 compare to earnings per share of $2.04 in the same quarter a year ago a decrease from $2.50 eps realized in I. Quarter (Mar 31 2020).


II. Quarter
Earnings Per Share Revenues
$ -4.84 $  1,445 Mill
$-6.88     $+241M     +20.05 %



Alexion Pharmaceuticals Inc 's Revenue rose by 20.05 % in II. Quarter (Jun 30 2020) year on year, to $1,445 million and declined by -0.01 % sequentially.


Alexion Pharmaceuticals Inc is Expected to report next financial results on February 11, 2021.

More on ALXN's Income Statement



Alexion Pharmaceuticals Inc 's in II. Quarter recorded net loss of $-1,068 million, compare to net income of $460 million achieved in II. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $557.60 million in previous quarter.

More on ALXN's Growth

Inventories grew by 16.8 % to $578 million from II. Quarter a year ago, sequentially inventories fell by -1.55 %. ALXN's Cash flow In II. Quarter company's net cash flow was $517 million, capital expenditures grew by -86.75%, to $-6 millions compare to same quarter a year ago and rose by -49.18% from I. Quarter (Mar 31 2020).

More on ALXN's Cash flow Statement


Alexion Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals Inc earned $ 11.13 cash per share, on a free-cash flow basis 297.71 % of net earning per share.

Book value fell by -9.89 % sequentially to $47.56 per share.
Tangible Book value grew to $ 15.21 per share from $ 11.18.

Company repurchased 2.00 million shares or 0.90 % in II. Quarter.
Interest Coverage Ratio was 6.04. Debt Coverage Ratio was 0.22.

More on ALXN's Dividends

 Market Capitalization (Millions) 26,472
 Shares Outstanding (Millions) 221
 Total Debt (Millions $) 2,438
 Revenue (TTM) (Millions $) 5,537
 Net Income (TTM) (Millions $) 846
 Cash Flow (TTM) (Millions $) 1,506
 Capital Exp. (TTM) (Millions $) -98
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273




Alexion Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals Inc earned $ 11.13 cash per share, on a free-cash flow basis 297.71 % of net earning per share.

Book value fell by -9.89 % sequentially to $47.56 per share.
Tangible Book value grew to $ 15.21 per share from $ 11.18.

Company repurchased 2.00 million shares or 0.90 % in II. Quarter.
Interest Coverage Ratio was 6.04. Debt Coverage Ratio was 0.22.

More on ALXN's Balance Sheets

 Market Capitalization (Millions) 26,472
 Shares Outstanding (Millions) 221
 Total Debt (Millions $) 2,438
 Revenue (TTM) (Millions $) 5,537
 Net Income (TTM) (Millions $) 846
 Cash Flow (TTM) (Millions $) 1,506
 Capital Exp. (TTM) (Millions $) -98
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CTIX's Profile

Stock Price

CTIX's Financials

Business Description

Fundamentals

Charts & Quotes

CTIX's News

Suppliers

CTIX's Competitors

Customers & Markets

Economic Indicators

CTIX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071